Moran Wealth Management LLC Buys 8,264 Shares of ALPS Medical Breakthroughs ETF $SBIO

Moran Wealth Management LLC lifted its stake in shares of ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO) by 39.2% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 29,348 shares of the company’s stock after purchasing an additional 8,264 shares during the quarter. Moran Wealth Management LLC owned 1.17% of ALPS Medical Breakthroughs ETF worth $1,536,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of SBIO. Exencial Wealth Advisors LLC raised its stake in ALPS Medical Breakthroughs ETF by 3.2% in the fourth quarter. Exencial Wealth Advisors LLC now owns 8,101 shares of the company’s stock valued at $415,000 after purchasing an additional 248 shares in the last quarter. Royal Bank of Canada grew its stake in ALPS Medical Breakthroughs ETF by 2.8% during the fourth quarter. Royal Bank of Canada now owns 12,269 shares of the company’s stock worth $628,000 after buying an additional 330 shares in the last quarter. McGuire Investment Group LLC grew its stake in ALPS Medical Breakthroughs ETF by 5.9% during the fourth quarter. McGuire Investment Group LLC now owns 8,798 shares of the company’s stock worth $451,000 after buying an additional 488 shares in the last quarter. Steward Partners Investment Advisory LLC bought a new position in ALPS Medical Breakthroughs ETF in the 4th quarter valued at about $26,000. Finally, Griffin Asset Management Inc. raised its position in shares of ALPS Medical Breakthroughs ETF by 1.9% in the 4th quarter. Griffin Asset Management Inc. now owns 30,699 shares of the company’s stock valued at $1,572,000 after buying an additional 564 shares in the last quarter.

ALPS Medical Breakthroughs ETF Stock Performance

Shares of ALPS Medical Breakthroughs ETF stock traded up $1.15 on Tuesday, reaching $65.99. 20,938 shares of the stock were exchanged, compared to its average volume of 35,750. The firm’s 50 day moving average is $55.46 and its 200-day moving average is $53.02. ALPS Medical Breakthroughs ETF has a one year low of $30.40 and a one year high of $66.68.

ALPS Medical Breakthroughs ETF Profile

The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is managed by ALPS.